JPRN-UMIN000018561尚未招募未知
Efficacy and safety of ledipasvir and sofosbuvir in patients with chronic hepatitis C - Efficacy and safety of ledipasvir and sofosbuvir
Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology0 个研究点目标入组 2,000 人开始时间: 2015年8月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Severe multisystem disease, Severe immnodeficiency 2) Patients with chronic renal failure or patients with hemodialysis 3) Contraindication to ledipasvir or sofosbuvir 4) Contraindication to ledipasvir and sofosbuvir
研究者
相似试验
已完成
不适用
Effectiveness and safety of ledipasvir and sofosbuvir for patients infected with HCV genotype 1 in clinical practicesChronic hepatitis C genotype 1JPRN-UMIN000024007Kyushu University1,000
已完成
不适用
Efficacy and safety of ledipasvir/sofosubuvir/ribavirin combination therapy for failures to daculatasvir/asunaprevir combination therapy.Patients infected with HCV genotype 1, who failed to daculatasvir/asunaprevir comnination therapy.JPRN-UMIN000022418Toranomon Hospital, Department of Hepatology.20
已完成
不适用
Prospective study of Sofosbuvir and Ledipasvir for HCV genotype 1 infected Japanese patientsGenotype 1 infected chronic liver diseasesJPRN-UMIN000019400Osaka City University and affiliated hospitals400
招募中
不适用
Evaluation of the efficacy of sofosbuvir and ledipasvir for Japanese hepatitis C patients: a prospective study in real-life settings.chronic hepatitis CJPRN-UMIN000019468Toranomon Hospital100
已完成
不适用
Efficacy and safety of Ledipasvir/Sofosbuvir in chronic hepatitis C of Genotype1b with chronic kidney disease(eGFR30-60ml/min/1.73m2)Chronic hepatitis CJPRN-UMIN000027851ippon Medical School Chiba Hokusoh Hospital700